A circuit mechanism for psychosis vulnerability during perimenopause
The transition to menopause is a period of profound physiological change that encompasses nearly one-third of a woman's lifespan and is associated with a distinct rise in the incidence of psychosis. Despite the clinical burden of menopause-associated psychosis, the circuit-level mechanisms linking reproductive aging to psychiatric vulnerability remain poorly defined. Current understanding is limited by rodent models that utilize abrupt surgical hormone loss, which fail to capture the progressive endocrine fluctuations and follicular depletion characteristic of the natural menopausal transition. Here, we investigate how the gradual transition from perimenopause to postmenopause regulates the ventral hippocampus-mesolimbic dopamine circuit, a pathway centrally implicated in the development of psychotic symptoms. Specifically, we show that the perimenopausal transition induces a transient state of ventral hippocampal hyperactivity that selectively drives dopamine system dysfunction, whereas this modulatory control is absent in the postmenopausal state. These findings reveal that psychosis-related circuit instability is precipitated specifically by the hormonal transition itself, rather than the persistent state of estrogen deficiency that follows. This contrasts with the long-standing "estrogen protection hypothesis," which posits that low hormone levels are the primary driver of symptoms and explains why standard hormone replacement and antipsychotic therapies often yield inconsistent results. Our results establish that perimenopause is a mechanistically distinct neurobiological window characterized by a unique failure of hippocampal-dopamine circuit regulation. By identifying this specific period of circuit instability, this work provides a framework for stage-specific psychiatric interventions and reframes reproductive aging as a series of distinct transitions in brain function.
Authors
- Stephanie M. Perez (ORCID: https://orcid.org/0000-0002-3258-4456)
- Daniel J. Lodge (ORCID: https://orcid.org/0000-0002-6772-1748)
- Angela M. Boley (ORCID: https://orcid.org/0000-0003-0253-1481)
- Hannah B. Elam (ORCID: https://orcid.org/0000-0002-6106-4011)
- Olivia J Yang (ORCID: https://orcid.org/0000-0002-9564-417X)
- Kayla Lilly (ORCID: https://orcid.org/0009-0008-7651-5031)
Institutions
- Vanderbilt University (US)
- Murphy Oil Corporation (United States) (US)
- South Texas Veterans Health Care System (US)
- The University of Texas at San Antonio (US)
Publication Details
- Journal
- Proceedings of the National Academy of Sciences
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1073/pnas.2613715123
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- National Institute on Aging
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- National Center for Advancing Translational Sciences